Fingerprint
Entra nei temi di ricerca di 'A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)'. Insieme formano una fingerprint unica.- Ordina per
- Peso
- Alfabetico
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
Erica Brivio, Franco Locatelli, Marta Lopez-Yurda, Andrea Malone, Cristina Díaz-De-Heredia, Bella Bielorai, Claudia Rossig, Vincent H.J. Van Der Velden, Anneke C.J. Ammerlaan, Adriana Thano, Inge M. Van Der Sluis, Monique L. Den Boer, Ying Chen, Barbara Sleight, Benoit Brethon, Karsten Nysom, Lucie Sramkova, Ingrid Øra, Luciana Vinti, Christiane Chen-Santel
- Princess Máxima Center for Pediatric Oncology
- Our Lady's Hospital for Sick Children
- Vall d’Hebron University Hospital
- Sheba Medical Center at Tel Hashomer
- University of Münster
- Erasmus University Rotterdam
- Pfizer
- Assistance publique – Hôpitaux de Paris
- University of Copenhagen
- Charles University
- Lund University
- University of Rome La Sapienza
- Charité – Universitätsmedizin Berlin
Risultato della ricerca: Contributo in rivista › Articolo in rivista